36 Two-year survival and tumor immune microenvironment dynamics in NACI study: an open-label, multi-centre, single-arm, phase 2 trial of neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer
Poster and E-Posters（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要